In a Bloomberg Law article, health care partner Mark Barnes discussed how ‘personhood’ law could threaten embryonic stem cell research in states seeking to give embryos and fetuses the same rights as people following the U.S. Supreme Court Dobbs decision overturning federal abortion rights.
Embryonic stem cells offer promise in health and medicine because they can turn into any cell in the human body, offering the potential to repair and regenerate tissue damaged by a range of diseases. They can also be used to screen drug candidates for toxicity.
Mark explains that if states grant personhood to embryos without specific exceptions for derivation of stem cells from embryos, then there can be no stem cells on which to do biomedical research or develop therapeutic products and research institutions might move their facilities to states without such laws.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.